Uganda Expanding Access to Long-Acting HIV Prevention Drug Lenacapavir

What the report says

KAMPALA — Uganda is expanding access to lenacapavir, a long-acting HIV prevention drug, as health officials report strong demand for the six-month injection, particularly among highly informed and financially empowered men. The drug is currently available free of charge through the Ministry of Health programme, with support from the Global Fund and manufacturer Gilead Sciences. […] The post Uganda Expanding Access to